Similar articles for PMID: 28551681

Year	Number of Results
1906	1
1982	1
1999	1
2003	1
2004	1
2005	2
2007	1
2008	1
2009	4
2010	3
2011	6
2012	13
2013	15
2014	19
2015	25
2016	26
2017	29
2018	36
2019	24
2020	21
2021	18
2022	7
2023	4
2024	7
2025	0

1

Neoadjuvant Chemoradiotherapy for Stage II or III Esophageal Squamous Cell Carcinoma.

Kawai T, Kochi M, Fujii M, Song K, Hagiwara K, Watanabe M, Matsuno Y, Suda H, Yagi R, Takayama T. Kawai T, et al. Anticancer Res. 2017 Jun;37(6):3301-3306. doi: 10.21873/anticanres.11697. Anticancer Res. 2017. PMID: 28551681

2

Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell Carcinoma.

Hamai Y, Hihara J, Emi M, Furukawa T, Ibuki Y, Yamakita I, Kurokawa T, Okada M. Hamai Y, et al. Anticancer Res. 2017 Oct;37(10):5639-5646. doi: 10.21873/anticanres.11999. Anticancer Res. 2017. PMID: 28982881

3

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients.

Fujiwara Y, Yoshikawa R, Kamikonya N, Nakayama T, Kitani K, Tsujie M, Yukawa M, Inoue M, Yamamura T. Fujiwara Y, et al. Oncol Rep. 2012 Aug;28(2):446-52. doi: 10.3892/or.2012.1847. Epub 2012 Jun 1. Oncol Rep. 2012. PMID: 22664791 Free PMC article.

4

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma.

Barbetta A, Hsu M, Tan KS, Stefanova D, Herman K, Adusumilli PS, Bains MS, Bott MJ, Isbell JM, Janjigian YY, Ku GY, Park BJ, Wu AJ, Jones DR, Molena D. Barbetta A, et al. J Thorac Cardiovasc Surg. 2018 Jun;155(6):2710-2721.e3. doi: 10.1016/j.jtcvs.2018.01.086. Epub 2018 Feb 15. J Thorac Cardiovasc Surg. 2018. PMID: 29548582 Free PMC article.

5

Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?

Hsu PK, Chien LI, Huang CS, Hsieh CC, Wu YC, Hsu WH, Chou TY. Hsu PK, et al. Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):460-6. doi: 10.1093/icvts/ivt216. Epub 2013 May 31. Interact Cardiovasc Thorac Surg. 2013. PMID: 23728085 Free PMC article.

6

Role of neoadjuvant treatment in clinical T2N0M0 oesophageal cancer: results from a retrospective multi-center European study.

Markar SR, Gronnier C, Pasquer A, Duhamel A, Beal H, Théreaux J, Gagnière J, Lebreton G, Brigand C, Meunier B, Collet D, Mariette C; FREGAT working group – FRENCH – AFC. Markar SR, et al. Eur J Cancer. 2016 Mar;56:59-68. doi: 10.1016/j.ejca.2015.11.024. Epub 2016 Jan 23. Eur J Cancer. 2016. PMID: 26808298

7

Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.

Cho HJ, Kim YH, Kim HR, Kim DK, Park SI, Kim JH, Kim SB. Cho HJ, et al. Ann Surg Oncol. 2015;22(6):1851-7. doi: 10.1245/s10434-014-4195-3. Epub 2014 Oct 25. Ann Surg Oncol. 2015. PMID: 25344308

8

Long-term outcomes following neoadjuvant chemoradiotherapy in patients with clinical T2N0 esophageal squamous cell carcinoma.

Chen WH, Chao YK, Chang HK, Tseng CK, Wu YC, Liu YH, Hsieh MJ, Liu HP. Chen WH, et al. Dis Esophagus. 2012 Apr;25(3):250-5. doi: 10.1111/j.1442-2050.2011.01243.x. Epub 2011 Sep 23. Dis Esophagus. 2012. PMID: 21951719

9

Esophageal adenocarcinoma stage III: Survival based on pathological response to neoadjuvant treatment.

Schwameis K, Zehetner J, Hagen JA, Oh DS, Worrell SG, Rona K, Cheng N, Samaan J, Green KM, Lipham JC. Schwameis K, et al. Surg Oncol. 2017 Dec;26(4):522-526. doi: 10.1016/j.suronc.2017.10.001. Epub 2017 Oct 14. Surg Oncol. 2017. PMID: 29113673

10

Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.

Chen Y, Hao D, Wu X, Xing W, Yang Y, He C, Wang W, Liu J, Wang J. Chen Y, et al. Dis Esophagus. 2017 Jul 1;30(7):1-7. doi: 10.1093/dote/dox016. Dis Esophagus. 2017. PMID: 28475725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 28551681

224 results

Results by year